Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial.
Autor: | Cunningham, David1 david.cunningham@rmh.nhs.uk, Lang, Istvan2, Marcuello, Eugenio3, Lorusso, Vito4, Ocvirk, Janja5, Shin, Dong Bok6, Jonker, Derek7, Osborne, Stuart8, Andre, Niko8, Waterkamp, Daniel8, Saunders, Mark P9 |
---|---|
Zdroj: | Lancet Oncology. Oct2013, Vol. 14 Issue 11, p1077-1085. 9p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |